Lilly has reported comprehensive outcomes from the Phase III trial of tirzepatide for individuals with heart failure with ...

Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

Eli Lilly has reported comprehensive outcomes from the SURMOUNT-1 study of tirzepatide for treating pre-diabetic and obese ...

Net Loss: Net loss attributable to common stockholders for the third quarter of 2024 was $ (3.1) million, or $ (1.92) per ...

Following a treatment-related serious adverse event (SAE) in the third participant dosed with 3E15 vg, Neurogene paused further use of the 3E15 vg dose and does not plan to enroll any further ...

USC professor Berislav Zlokovic is on leave after whistleblowers cast doubt on his published work and derailed trials for an ...

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma ...

Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value ...

Cervical cancer continues to pose a significant global health challenge, particularly in low- and middle-income countries, with more than 662,000 new cases and 348,900 reported deaths in 2022. The ...

Under the agreement, Roche will supply atezolizumab globally and Tempest will sponsor and lead the pivotal study. The ...

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a ...